EUA
ExProbe SARS-CoV-2 Testing Kit
FDA Emergency Use Authorization · TBG Biotechnology Corp. · Aug 27, 2021
Key facts
| Product | ExProbe SARS-CoV-2 Testing Kit |
|---|---|
| Company | TBG Biotechnology Corp. |
| Product type | Real-time RT-PCR, Multiple Targets |
| Date | Aug 27, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: